abstract |
The present invention provides an mRNA molecule that encodes at least one KRAS variant peptide. Further, the present invention provides a pharmaceutical composition and a kit containing the mRNA molecule. The mRNA molecule, pharmaceutical composition, and kit are useful in the treatment of cancer. [Selection diagram] None |